Newsletter: NGTF, One consumer food company that i
Post# of 103040
Ice Cream is among the most popular snacks consumed in the U.S at night. In fact, 49% of consumers snack on ice cream at night , an incredible figure. With the annual snack spend topping 50 Billion dollars the market for ice cream is a multi-billion dollar a year opportunity. For millions of consumer, ice cream is their #1 nighttime treat, making up a significant percentage of the 1 Billion dollars a week spent on nighttime snacks. One company is quickly taking advantage and gaining tremendous market share by offering Ice cream lovers a functional ice cream that is winning awards for taste and health consciousness. That company is Nightfood Inc. (OTCQB:NGTF.)
Nightfood is quickly growing distribution throughout the country. They have recently made substantial deals putting Nightfood ice cream on the shelves of major supermarket chains including Kroger's "Harris Tweeter", Albertson's "Jewel Osco", and Albertson's "Shaw's and Star Markets" giving Nightfood Ice cream access to shoppers in approximately 700 stores across the mid-Atlantic, northeast, and upper Midwest. Nightfood reorder Q1 sales increased significantly compared to prior quarter sales and we expect exponential sales to continue as management continues its national roll-out in the near term.
The thesis behind Nightfood's tremendous demand and ultimate success in the marketplace is that the $50 billion nighttime snack category is ripe for innovation and domination. 80% of consumers snack regularly at night, with ice cream at the top of the list for millions. Consumers know they shouldn’t be eating junk at night, over 50% report feeling guilty and out of control about their night snacking, while most are also dissatisfied with their sleep quality. There is a tremendous gap in the marketplace for Nightfood to fill.
Nobody eats more ice cream at night than pregnant women, and Nightfood recently secured a major endorsement as the Official Ice Cream of the American Pregnancy Association (APA). There are over 3 million pregnant women in the U.S. at any given time. Investors that have seen a boom in plant-based meats and other brands servicing the vegan consumer should note that the vegan population is dwarfed by the pregnancy population.
The APA is recommending Nightfood to all pregnant women because Nightfood is a healthier choice for this ultra health-conscious market segment. Nightfood has more calcium, magnesium, and zinc. Higher in fiber and protein, and with less sugar, less fat and fewer
calories, it is also lower glycemic than regular ice cream. They even added digestive enzymes and amino acids that fight the heartburn associated with pregnancy.
We believe consumer demand associated with the American Pregnancy Association endorsement will be a huge catalyst in Nightfood’s ongoing national roll-out.
With Nightfood's reorder sales velocity increasing sharply in Quarter one it is easy to see exponential sales growth occurring for Nightfood Ice cream as they ramp up distribution to additional grocery chains and new distribution channels. The stock is cheap trading near its 52 week low when revenues and distribution are accelerating . We expect the intrinsic value will be unleashed with the anticipated announcements of more stores offering Nightfood ice cream while the popularity of the product should lead to more shelf space for additional skus multiplying sales growth and creating a true growth stock story. We believe NGTF is significantly undervalued based on its growth rate and are looking for fresh 52 week highs with Press Releases detailing further distribution channels.
We give NGTF a HUGE thumbs up!
Share Structure
Market Cap
12,059,808
04/03/2020
Authorized Shares
200,000,000
04/01/2020
Outstanding Shares
60,148,666
04/01/2020
Restricted
20,003,503
04/01/2020
Unrestricted
40,145,163
04/01/2020
Held at DTC
39,257,305
04/01/2020
Float
34,890,568
10/11/2019
Private Equity Markets was compensated 3,200.00 as part of a long term , ongoing package of services, including the dissemination of this report. This is not investment advice. Please view the disclaimer found on this website.